Hi David, from the Wired article:

 

But the Journal’s first article said that their tech wasn’t up to the task, and instead the company diluted the blood and ran it through standard industry diagnostic machines. The second article said the FDA outright recommended that the company stop using all but one test, for herpes simplex I—the only one the FDA has cleared for use outside of Theranos labs.”

 

http://www.wired.com/2015/10/theranos-isnt-the-only-one-chasing-needle-free-blood-tests/

 

On EQA, this gives some interesting insights:

http://www.fiercemedicaldevices.com/story/wsj-former-theranos-employees-reveal-problems-proprietary-testing-device/2015-10-16

 

Stuart

 

 

 

 

From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of David Hardy
Sent: 18 October 2015 17:30
To: [log in to unmask]
Subject: Re: Theranos

 

Warning: This message contains unverified links which may not be safe.  You should only click links if you are sure they are from a trusted source.

I know this topic comes up on a semi-regular basis, but it is fascinating that there is so much “value” ($9bn) in something seemingly so clandestine. Yes, I know it is a commercial operation and there is the matter of intellectual and commercial confidentiality (yada yada), but I am left wondering (naively, perhaps, due to middle-age decline) about a few things. I have to admit that I have not read the WSJ article (other things to do with my money), but from the Forbes article I wonder:

 

1.       To market these test methodologies commercially, would they not have to produce at least a 510K submission to the FDA? If not, would there not be some regulatory requirement? I got the impression that this was (at least partly) their proprietary technology, so they are not quite in the same position as the local Wal-Mart doing cholesterol testing. And I can’t believe the same technology is used for HSV testing and K+, so one test does not cover all!

2.       What about EQA? If they belong to a scheme that data would be confidential, but do they belong to appropriate schemes? If yes, why not use this in their defence against the criticisms? (If not, why not?)

3.       Has anyone done what Carreyrou appears to have passed on, and sent comparative samples to them and a traditional contract lab (with traditional EQA)? I don’t recall ever seeing this mentioned.

 

Maybe I am missing something because, although still interested in the area, I am now doing other things. But these are obvious questions to me from my experience of analytical clinical biochemistry. If anyone can comment (if only to set right my personal ignorance) I would be interested in the replies.

 

Best wishes,

 

Dave

 

David Hardy PgDip MSc PhD CSci CChem MRSC FIBMS

Freelance Scientific Writer and Tutor

Simply Infocation

 

T: 01531 635152

M: 07957655580

W: www.simplyinfocation.net

      www.davidhardytutor.com

In: https://uk.linkedin.com/pub/david-hardy/b/a11/687

 

 

 

From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of Bakkeren, DL
Sent: 18 October 2015 16:21
To: [log in to unmask]
Subject: Re: Theranos

 

And also read this: http://onforb.es/1LPvfSW

Theranos' Elizabeth Holmes Needs To Stop Complaining And Answer Questions - Forbes

 

 

Dirk Bakkeren, PhD 
Laboratory specialist clinical chemistry

Dr. D.L. Bakkeren | Clinical Laboratory
PO box 7777
5500 MB Veldhoven
T: +31-408888900
F: +31-408888029

E: [log in to unmask]

 


Van: Clinical biochemistry discussion list [mailto:[log in to unmask]] Namens Mohmed Ashmaig
Verzonden: zondag 18 oktober 2015 16:51
Aan:
[log in to unmask]
Onderwerp: Theranos

 

Very interesting article about Theranos:

 

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/
Deze e-mail en de daarmee verzonden informatie is uitsluitend bestemd voor de geadresseerde en kan onderworpen zijn aan een beroepsgeheim. Openbaarmaking, vermenigvuldiging, verstrekking aan en/of gebruik door derden van deze informatie zonder toestemming van de afzender, is niet toegestaan. Indien u niet de geadresseerde bent of dit bericht abusievelijk aan u is toegezonden, wordt u vriendelijk verzocht dat aan de afzender te melden en het bericht te verwijderen. Máxima Medisch Centrum staat niet in voor de juiste en volledige overbrenging van de inhoud van een verzonden bericht, noch voor tijdige ontvangst daarvan en ook niet voor het zonder inbreuk of tussenkomst van onbevoegde derden overbrengen van het bericht.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

Barking, Havering & Redbridge University Hospitals NHS Trust: Working to make our hospitals better.

This communication, together with any files or attachments transmitted with
it contains information which is confidential and may be subject to legal 
privilege and is intended solely for the use by the person(s) or entity to 
whom it is addressed. If you are not the intended recipient you must not 
copy, distribute, publish or take any action in reliance on it. If you have 
received this communication in error, please notify 
[log in to unmask] and delete it from your computer systems.

Barking, Havering & Redbridge University Hospitals NHS Trust reserves the 
right to monitor all communications for lawful purposes. Receipt of this email 
does not imply consent to use or provide this email address, or any others 
contained therein, to any third party for any purposes. The contents of this
email are protected under international copyright law.

To save energy and paper please print this email only if you really need to. 
_____________________________________________________________________________

This email has been scanned for viruses using antivirus software by 
Barking, Havering & Redbridge University Hospitals NHS Trust. Whilst every
care is taken to avoid the transmission of virus code; please ensure that you 
have up to date virus detection software before opening any E-mail 
messages or attachments 
______________________________________________________________________________

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/